MAR 09, 2017 07:49 PM PST

T Cells "Loosen Up" to Recognize Pathogens Better and Faster

WRITTEN BY: Kara Marker

Senior author of a new Science Signaling study Dr. Manish Butte describes T cells as like “the shy person at the office holiday party who acts stiff until they loosen up a bit.” Butte is talking about T cells interacting with antigen-presenting cells, because the reaction between these two literally depends on whether T cells are loose or stiff.

T cells are produced in the thymus and promote cell-mediated immune response, also known as the adaptive immune response. Credit: Pulmonary Fibrosis News

Antigen-presenting cells (APCs) display bits of pathogenic or cancerous proteins, waiting for T cells that are designed to recognize the specific antigens they are displaying on their cell surface in order to trigger an immune response. A T cell interaction with an antigen-presenting cell (APC) occurs in three steps.

  1. The initial fraternization: A T cell binds to an APC to see if there is a match

  2. The identification: The T cell recognizes an antigen on an APC and communicates with the APC to find other potential nearby APCs displaying the same antigen

  3. The activation: As the T cell continues to bind to the APC, it becomes activated, a process necessary for T cells to dive into the bloodstream prepared to find the pathogen the APC was trying to warn the T cell about

With these steps fully understood, Butte and other researchers from the University of California Los Angeles Health Sciences turned to investigate another factor that matters in the scheme of the immune response: the stiffness or softness of the T cells; stiff cells react more slowly to activation than soft cells.

"Until now, we had a limited understanding of what controls T cell activation," Butte explained. "We wanted to identify how to both encourage and speed up T cell activation for fighting infections and cancers and to disrupt it in order to prevent immune disease. Now that we understand the precise steps taking place, our findings suggest that altering T cell stiffness with drugs could one day help us thwart diseases where T cells are too active or not active enough."

Butte introduced a new approach to observe T cell activity in real-time at the nano-level: a technology called an atomic-force microscope. This approach helped them identify the pathway in charge of a T cell being stiff instead of soft, allowing a future opportunity for the development of drugs that can mimic the natural pathway toward T cell softness, introducing an entirely new way to manipulate the immune system.

"We can't talk about precision medicine and still use a sledgehammer to treat disease," Butte said. "By exploiting the mechanism we discovered to soften T cells, we could accelerate vaccine responses so a patient won't need multiple boosters and months of waiting to get full immunity. Or we could stiffen up T cells to prevent the body from rejecting transplanted organs."

Source: University of California Los Angeles Health Sciences

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
NOV 26, 2018
Health & Medicine
NOV 26, 2018
A New Test for Fibromyalgia
Anyone who has experienced severe, chronic pain knows the long process it takes to get a correct diagnosis. Many people see an average of 5-6 specialists b...
JAN 15, 2019
Immunology
JAN 15, 2019
Unconventional T Cells
Spondyloarthritis is one of the most common types of chronic joint inflammation affecting nearly 1-2 percent of the Western population. Scientists report that rare populations of unconvention...
JAN 20, 2019
Drug Discovery
JAN 20, 2019
Combination Therapeutic Effective for Leishmaniasis and HIV Patients
In a study published in PLOS Neglected Diseases, a special combination therapy has been proven for efficacy in cases of coinfection with Visceral leishmani...
MAR 19, 2019
Health & Medicine
MAR 19, 2019
Can a Low-Carb Diet Treat Osteoarthritis?
A pilot study suggests it might. Researchers at the University of Alabama, Birmingham, found that a low-carbohydrate diet was able to reduce pain intensity...
APR 09, 2019
Health & Medicine
APR 09, 2019
Toxic Air is Shortening Children's Lifespans
According to the State of Global Air 2019 report, air pollution is currently shortening life expectancy by an average of 20 months worldwide. This means th...
APR 11, 2019
Health & Medicine
APR 11, 2019
Drug-resistant Candida Auris is Spreading
A drug-resistant fungal yeast, Candida auris, is spreading throughout hospitals worldwide. Deemed “an urgent threat” by the Center for Disease...
Loading Comments...